Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension
A terminated clinical trial by Novoic Limited studied predicting amyloid status in early-stage Alzheimer's disease using acoustic and lingui…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment. [NA]
VINCI-AD, a trial evaluating transcutaneous vagus nerve stimulation in mild cognitive impairment, has completed. The study lists mild cognit…
-
CLINICAL_TRIALS other · 2024-06-14Clinical Trial Update: Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Clinical trial update on amyloid prediction in early-stage Alzheimer's disease through speech phenotyping (FUTURE Extension) indicates the s…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Dapagliflozin In Alzheimer's Disease [Phase 1, Phase 2]
This document reports the completion and results posting of Phase 1/2 trials evaluating dapagliflozin for Alzheimer's disease.
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease [NA]
A clinical trial investigating the impact of microglial activation on synaptic density in Alzheimer's disease is currently recruiting, spons…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD [Phase 2]
A Phase 2 clinical trial evaluating low-dose interleukin-2 as an immunomodulatory treatment for early Alzheimer's disease is currently recru…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein
This clinical trial update describes implementing dementia care management into routine care in the Siegen-Wittgenstein region, sponsored by…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: A Pilot Study of Deep Cervical Lymphatic-venous Anastomosis in the Treatment of Alzheimer's Disease
A pilot clinical trial is evaluating deep cervical lymphatic-venous anastomosis as a treatment for Alzheimer's disease; the study is current…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: DHA Brain Delivery Trial [Phase 2]
Phase 2 trial evaluating brain delivery of docosahexaenoic acid (DHA) to assess Alzheimer's disease risk has completed.
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Decisions About Cancer Screening in Alzheimer's Disease [NA]
A clinical trial update on decisions about cancer screening in individuals with Alzheimer's disease; the study is completed and results were…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Nutrition Interventions for Cognitive Enhancement [NA]
The clinical trial 'Nutrition Interventions for Cognitive Enhancement' sponsored by University of Kansas Medical Center for Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: A Family-centered Intervention for Acutely-ill Persons With Dementia [NA]
Completed clinical trial evaluating a family-centered intervention for acutely ill persons with dementia; results posted.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Accelerated Intermittent Theta-burst Stimulation to Modify Cognitive Function and Balance in Dementia and Memory Loss [NA]
This clinical trial update from McMaster University describes an accelerated intermittent theta-burst stimulation approach intended to modif…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: SV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration
A clinical trial update evaluating a combined SV2A-PET/CT and PET/MRI clinical criteria score for diagnosing early cognitive alteration in A…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease
A clinical study is exploring whether peripheral blood microRNAs relate to the risk and severity of Alzheimer's disease and is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) [NA]
A clinical trial update indicates that electroconvulsive therapy is being studied for agitation in Alzheimer's disease, and the trial is cur…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type. [Phase 4]
Phase IV trial evaluating the safety, tolerability, and effectiveness of rivastigmine transdermal patch (15 cm²) in patients with severe Alz…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Developments of Novel Virtual Visual and Haptic Stimulation Systems for the Elderly [NA]
This update notes the completion of a clinical trial evaluating novel virtual visual and haptic stimulation systems for elderly participants…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Feasibility Study of a Community Pilot Project for the Prevention of Alzheimer's Disease: the KetoHome Study. [NA]
This completed feasibility study evaluates a community-based KetoHome intervention aimed at preventing Alzheimer's disease, with measurement…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain [NA]
This clinical trial investigates how APOE genotype affects triglycerides and brain blood flow in individuals with Alzheimer’s disease or dem…
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Health Evaluation in African Americans Using RAS Therapy [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating safety and health outcomes of RAS Therapy in African American individuals with Alzheimer's diseas…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Phase II Clinical Trial of Interleukin-2 in AD [Phase 2]
A Phase II clinical trial evaluating interleukin-2 for Alzheimer’s disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) [Phase 3]
Phase 3 TRAILBLAZER-ALZ 2 trial update for donanemab in early Alzheimer's disease with results posted in May 2024.
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Alzheimer"s Imaging Biomarkers in Obesity
A clinical trial is studying imaging biomarkers related to Alzheimer's disease in people with obesity. The study is currently recruiting.
-
FDA approval · 2024-05-17FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Carlsbad Technology, Inc.)
The FDA approved a supplemental application for memantine hydrochloride from Carlsbad Technology, Inc., approving changes to the approved ge…